Skinvisible Inc (SKVI) Financial Statements (2026 and earlier)

Company Profile

Business Address 6320 S SANDHILL ROAD
LAS VEGAS, NV 89120
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3101816636
Cash and cash equivalent3101816636
Receivables55271908
Other undisclosed current assets20278987
Total current assets:2842351107450
Noncurrent Assets
Intangible asset, including goodwill, after accumulated amortization100116127137153150
Intangible asset, excluding goodwill, after accumulated amortization100116127137153150
Total noncurrent assets:100116127137153150
TOTAL ASSETS:128158163247227200
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,2548594391,2021,040865
Interest and dividends payable✕✕✕✕✕1,4751,021
Accrued liabilities3,3572,7852,5761,956  
Other undisclosed accounts payable and accrued liabilities(2,103)(1,926)(2,137)(754)(435)(156)
Debt45136   
Due to related parties✕✕✕✕ 2752
Other undisclosed current liabilities3,7192,8073,0682,4431,9941,801
Total current liabilities:5,0183,6803,5123,6453,0612,719
Noncurrent Liabilities
Long-term debt and lease obligation5,3725,3725,372  220
Long-term debt, excluding current maturities5,3725,3725,372  220
Other undisclosed noncurrent liabilities  3523013,2422,5821,716
Total noncurrent liabilities:5,3725,7245,6743,2422,5821,936
Total liabilities:10,3909,4049,1866,8875,6434,655
Equity
Equity, attributable to parent(10,263)(9,246)(9,023)(6,641)(5,416)(4,455)
Common stock555555
Additional paid in capital30,74230,68530,35330,35330,35330,241
Accumulated deficit(41,010)(39,946)(39,380)(36,998)(35,773)(34,700)
Other additional capital  10    
Total equity:(10,263)(9,246)(9,023)(6,641)(5,416)(4,455)
TOTAL LIABILITIES AND EQUITY:128158163247227200

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues202020279663153
Revenue from related parties✕✕✕✕  123
Other income5     
Cost of revenue    (5)(3) 
Other undisclosed gross profit      123
Gross profit:202020274660276
Operating expenses(516)(610)(510)(513)(472)(529)
Other operating expense, net
(Other Expenses)
   (1,892)(986)(1,261)(1,194)
Other undisclosed operating income   1,8929861,2611,194
Operating income (loss):(496)(590)(490)(238)188(254)
Interest and debt expense  697(1,887)(1,018)(1,103)(1,194)
Income (loss) from continuing operations:(496)108(2,378)(1,257)(915)(1,448)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(915)(1,448)
Net income (loss):(496)108(2,378)(1,257)(915)(1,448)
Other undisclosed net income (loss) attributable to parent(568)(673)(5)32(157) 
Net loss available to common stockholders, diluted:(1,064)(566)(2,382)(1,225)(1,073)(1,448)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):(496)108(2,378)(1,257)(915)(1,448)
Comprehensive income (loss), net of tax, attributable to parent:(496)108(2,378)(1,257)(915)(1,448)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: